Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 10 of 89 trials
S2000
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Adult (18-64)
Older adult (65+)
STR-001-001
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
Adult (18-64)
Older adult (65+)
EA2182
Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study
Adult (18-64)
Older adult (65+)
EA2183
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body
Adult (18-64)
Older adult (65+)
N0577
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
Adult (18-64)
Older adult (65+)
EA1151
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer
Adult (18-64)
Older adult (65+)
NCI-2022-01540
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Adult (18-64)
Older adult (65+)
EAA173
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Adult (18-64)
Older adult (65+)
EA4151
Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
Adult (18-64)
Older adult (65+)
E4512
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Adult (18-64)
Older adult (65+)